The PSVER has been studied in a large group or normal controls and patients with neurologic diseases. With the development of more stable stimulation techniques, powerful amplifiers and computers able to sum and average the evoked potentials and exclude the background noise (EEC, muscle artifacts) the ER became clinically useful.
TECHNICAL CONSIDERATIONS
The patient sits one meter from a TV monitor and fixates on a small dot in the center of the screen where an alternating checkerboard pattern of black and white squares is seen. The patient wears his usual glasses. Each eye is tested separately, with a patch placed over the opposite eye. Scalp electrodes are placed in the occipital region at 0 , 0 and 0 (international 10-20 system) with a vertex reference (CZ). Linked ears are used as an alternative reference. Electrodes are attached to the scalp with collodion and electrolytic paste is used to maintain impedances below 6000 ohms.
Routinely the low linear frequency filter is set at 1 Hertz (Hz) and the high frequency filter at 100 Hz. The whole screen subtends 16 degrees of visual angle and each individual square 6.88' of arc (or 3.44' when smaller sized stimuli are used). A total of 200 msec is average over 128 trials for each check size and for each eye. The averaging process is displayed on an oscilloscope to monitor artifacts and the final result is recorded with an X-Y plotter. The whole procedure takes about 30-40 minutes.
RESULTS AND INTERPRETATION
The PSVER has a prominent major down going (positive) wave with a peak at approximately 100 msec latency, called the P100 or P2 (case 1 - figure 1 ). Smaller components (PI, Nl, and N2) are usually present but are not considered clinically important. It is assumed that the P100 is generated by neurons of the primary occipital cortex (area 17). Normative data for each laboratory is mandatory 18.
The 21 controls in our laboratory showed a fiirst positive wave mean ( x*) of 104.60 msec ± a standard deviation (SD) of 5.02. The intereye difference for latency should be less than 8.5 msec (Τ) ψ 3 SD).
Several factors may affect the latency and amplitude of P100 and they have to be taken into consideration: age, level of arousal, pattern luminance, pattern contrast, EEG amplifier filters, stimulation rate and type of stimulation 6.18.
The test presumes an absence of ocular pathology anterior to the optic nerve and retina. Visual acuity does not seriously affect P100 latency until it reaches 20/200 or worse (when the patient can not see the checkerboard). The P100 amplitude, however, Is more closely related to visual acuity.
The abnormal responses primarily related to latency and are defined as greater than 3.0 SD. We do not consider amplitude criteria, unless there is no measurable peak.
Once ocular pathology is excluded, the delay in latency of PSVER is a reliable index of a disturbance in the optic pathway.
CASES FOR ILLUSTRATION
Case 1 -Normal control (Fig. 1) . 13 . Two basic pathologies of peripheral nerve fibers are focal segmental demyelination and axonal loss. In the former, axonal transmission across the area of demyelination is preserved but at a slower velocity. A good example of this is seen in MS with ON. In cases with axonal loss, axonal transmission is interrupted and no conduction of nerve impulses is possible (conduction block). Ischemic optic neuropathy 22 is an example of axonal loss. At the moment the best indications for PSVER are: 1) to exclude an asymptomatic lesion in the visual system, or 2) to document a presumed lesion and corroborate the diagnosis of MS. In hysterical blindness it may be used to demonstrate a normal conduction. It can show any involvement of the optic system in neurologic diseases, even when subclinical 1. 5 . 7 , 17 .
PSVER is a very sensitive and reliable diagnostic test in the investigation

SUMMARY
The technique that we use for pattern shift visual evoked response (PSVER) is described. PSVER is a non-invasive, practical and reliable clinical test in detecting anterior visual pathways lesions even when asymptomatic. The ability to find unsuspected lesions in multiple sclerosis, making possible an early diagnosis, is underscored. We also discuss some pathophysiologic aspects and the findings of the PSVER in some neurologic disorders with visual system involvement.
RESUMO
Potencial evocado visual por padrão alternante: aplicação em Neurologia.
Potencial evocado visual por padrão alternante (PEV) é a resposta elétrica obtida pela estimulação visual através de um padrão alternante de quadrados brancos e pretos num vídeo de televisão. Isto é possível graças a um computador que realiza a promediação ("averaging") e é capaz de captar a resposta evocada no couro cabeludo e eliminar os ruidos (EEG, artefatos musculares e de movimentos).
Este teste, não invasivo, tem sido reconhecido universalmente como um método prático, confiável e muito sensível na detecção de patologia do sistema visual anterior ao quiasma ótico. Normalmente uma onda positiva ao redor de 100 msec (Ρ100) é registrada. Presume-se que este potencial seja originado em neurônios no córtex occipital primário (área 17). O principal parâmetro de anormalidade é a latência deste potencial P100. A acuidade visual não se relaciona com a latência de Ρ100 mas sim com a amplitude.
Excluída patologia do globo ocular (degeneração retiniana e glaucoma), assimetria de latência do potencial Ρ100, estatisticamente significante para os valores normais do laboratório, indica lesão do nervo óptico do lado envolvido. A causa mais comum do retardo do potencial Ρ100 é doença desmielinizante. Com o PEV é possível fazer-se o diagnóstico precoce de esclerose múltipla (EM) mesmo em pacientes que não apresentam queixas visuais. Uma lesão compres¬ siva do nervo óptico pode simular a anormalidade das doenças desmielinizantes, ainda que o grau do retardo do potencial Ρ100 seja, em geral, menor. Com características diversas da EM, principalmente com relação à simetria do comprometimento da latência e da amplitude do potencial Ρ100, tem-se descrito PEV anormal nas seguintes entidades nosológicas: anemi perniciosa, neuropatia óptica isquêmica, ambliopia por tabaco-álcool. doença de Jakob-Creutzfeldt, adrenoleu¬ codistrofia, panencefalite esclerosante subaguda, doença de Parkinson e degene¬ rações espino-cerebelares.
